HIGHER INCIDENCE OF OVARIAN HYPERSTIMULATION SYNDROME AFTER GNRH-AGONIST/HMG THERAPY

被引：8
|
作者：
LINDNER, C [1 ]
BRAENDLE, W [1 ]
KOHLER, S [1 ]
BETTENDORF, G [1 ]
机构：
[1] UNIV HAMBURG,FRAUENKLIN EPPENDORF,ZENTRUM REPROD MED,D-2000 HAMBURG 20,FED REP GER
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 1989年 / 49卷 / 04期
关键词：
D O I：
10.1055/s-2008-1026597
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：337 / 344
页数：8
相关论文
共 50 条
  • [1] INCIDENCE OF SEVERE OVARIAN HYPERSTIMULATION SYNDROME AFTER GNRH AGONIST/HMG SUPEROVULATION FOR INVITRO FERTILIZATION
    SMITZ, J
    CAMUS, M
    DEVROEY, P
    ERARD, P
    WISANTO, A
    VANSTEIRTEGHEM, AC
    HUMAN REPRODUCTION, 1990, 5 (08) : 933 - 937
  • [2] GnRH-Agonist Triggering to Avoid Ovarian Hyperstimulation Syndrome: A Review of the Evidence
    Martinez, Maria Cerrillo
    Ruiz, Francisco J.
    Garcia-Velasco, Juan A.
    CURRENT DRUG TARGETS, 2013, 14 (08) : 843 - 849
  • [3] COMBINED GNRH-AGONIST AND HMG THERAPY IN PATIENTS WITH STIMULATION FAILURE
    LOUTRADIS, D
    KALLIANIDIS, K
    SISKOS, K
    BLETSA, R
    CREATSAS, G
    MICHALAS, S
    ARAVANTINOS, D
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1991, 36 (04) : 317 - 321
  • [4] GnRH-Agonist Ovulation Trigger in Patients Undergoing Controlled Ovarian Hyperstimulation for IVF with Stop GnRH-Agonist Combined with Multidose GnRH-Antagonist Protocol
    Orvieto, Raoul
    Nahum, Ravit
    Zohav, Efraim
    Liberty, Gad
    Anteby, Eyal Y.
    Meltcer, Simion
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2021, 86 (05) : 427 - 431
  • [5] Comparison of the luteal phase after pituitary suppression with GnRH-agonist versus GnRH antagonist in controlled ovarian hyperstimulation.
    Willman, SP
    Kliman, HJ
    FERTILITY AND STERILITY, 2005, 84 : S308 - S308
  • [6] GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol
    Orvieto, Raoul
    Nahum, Ravit
    Zohav, Efraim
    Liberty, Gad
    Anteby, Eyal Y.
    Meltcer, Simion
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (01) : 51 - 53
  • [7] Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonist
    Kolanska, K.
    Cohen, J.
    Bendifallah, S.
    Selleret, L.
    Antoine, J. -M.
    Chabbert-Buffet, N.
    Darai, E.
    d'Argent, E. -M.
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2017, 46 (09) : 681 - 686
  • [8] RETRACTED: Clinical Pregnancy and Incidence of Ovarian Hyperstimulation Syndrome in High Ovarian Responders Receiving Different Doses of hCG Supplementation in a GnRH-Agonist Trigger Protocol (Retracted Article)
    Shen, Xiuzhen
    Yang, Qinjie
    Li, Lanfang
    Lu, Wenhao
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [9] Severe ovarian hyperstimulation syndrome after combined GnRH-agonist and low-dose human chorionic gonadotropin trigger in a patient with a single kidney
    Pereira, Nigel
    Lekovich, Jovana P.
    Kligman, Isaac
    Rosenwaks, Zev
    GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 (08) : 593 - 597
  • [10] A case of ovarian hyperstimulation syndrome using GnRH agonist to trigger oocyte maturation after cotreatment with GnRH antagonist
    Kovachev, E.
    13TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI) HELD JOINTLY WITH THE GERMAN SOCIETY OF OBSTETRICS & GYNECOLOGY, 2010, : 329 - 332
12345